跳至主要内容
临床试验/CTRI/2023/06/054377
CTRI/2023/06/054377尚未招募3 期

Comparative Clinical Study To Evaluate The Efficacy Of Dadru Gajendra Sinh Lepa And Terbinafine Ointment In Management Of Dadru Kushtha W.R.T Tinea Cruris .

Dr Priyanka Pandurang Panchal1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年6月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Relief from subjective assessment criteria i.e clinical signs and symptoms of dadru kushta such as redness (raga),pustules (Pidaka), itching(kandu) ,number of mandals, size of mandals

研究概览

简要总结

This study is Randomised ,Two arm ,Open labelled ,Control clinical study and Interventional type of study comparing the efficacy of Dadru Gajendra Sinh Lepa and Terbinafine Ointment local appication twice in a day for 21 days in 80 patients with patients having symptoms of Dadru kushtha that will be conducted in D Y Patil University  School of Ayurveda Nerul Navi Mumbai and patients will be selected from opd ,ipd of  D Y Patil Ayurvedic Hospital Nerul

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • i)Patients willing to participate in this trial through written informed consent ii)Patients who are 18 years to 70 years of any sed iii)Patients having specific symptoms of dadru kushtha iv)Patients who have controlled DM.

排除标准

  • i)Person with age below 18 years and with age above 70 years ii)Person having severe/chronic hepatic/renal diseases iii)Person with chronic infectious disease such as active Tuberculosis,Hepatitis B or C,or HIV iv)Chronicity more than 2 years v)Pregnant women and lactating mothers.

结局指标

主要结局

Relief from subjective assessment criteria i.e clinical signs and symptoms of dadru kushta such as redness (raga),pustules (Pidaka), itching(kandu) ,number of mandals, size of mandals

时间窗: Baseline,after 7 days for 21days

次要结局

未报告次要终点

研究者

发起方
Dr Priyanka Pandurang Panchal
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验